Research Article

Locally Different Endothelial Nitric Oxide Synthase Protein Levels in Ascending Aortic Aneurysms of Bicuspid and Tricuspid Aortic Valve

Table 3

Protein levels of 35 apoptosis-related proteins after treatment of HAECss with 1 mM L-NAME.

ProteinControl average1 mM L-NAME averageChangeP

Bad62.83 ± 4.8866.76 ± 12.673.920.661
Bax52.36 ± 16.3654.62 ± 12.142.260.878
Bcl-235.77 ± 6.5240.28 ± 4.954.510.373
Bcl-x20.18 ± 5.1817.03 ± 3.48−3.160.410
Pro-Caspase 392.79 ± 10.6789.73 ± 9.55−3.060.756
Cleaved Caspase 329.29 ± 7.8423.81 ± 3.32−5.480.392
Catalase58.39 ± 12.3555.87 ± 6.19−2.530.803
clAP-135.59 ± 9.1627.73 ± 16.97−7.870.560
clAP-215.76 ± 3.6216.86 ± 5.571.100.813
Claspin18.69 ± 2.8718.00 ± 2.51−0.690.745
Clusterin35.62 ± 11.6939.72 ± 4.574.100.660
Cytochrome c62.37 ± 11.0784.29 ± 6.9221.920.069
TRAIL R1/DR456.01 ± 3.1557.91 ± 12.801.910.833
TRAIL R2/DR588.48 ± 1.0391.83 ± 8.183.350.516
FADD72.14 ± 8.1572.21 ± 7.400.070.989
Fas/TNFSF641.58 ± 7.3734.54 ± 9.89−7.040.303
HIF-1a28.35 ± 7.4626.07 ± 6.38−2.290.735
HO-1/HMOX1/HSP3230.43 ± 6.3826.90 ± 12.93−3.530.728
HO-2/HMOX235.86 ± 1.9434.72 ± 11.64−1.150.887
HSP2741.67 ± 9.2544.93 ± 11.153.260.699
HSP6062.68 ± 8.6570.54 ± 22.297.870.640
HSP7065.35 ± 7.4269.88 ± 17.354.530.727
HTRA2/Omi78.98 ± 5.6484.13 ± 9.005.150.482
Livin12.39 ± 2.8517.58 ± 6.455.180.315
PON241.23 ± 2.4744.50 ± 12.633.270.711
p21/CIP1/CDNK1A30.05 ± 11.2435.52 ± 9.315.470.611
p27/Kip130.42 ± 3.6729.70 ± 4.48−0.730.777
Phospho-p53 (S15)22.92 ± 6.5825.48 ± 6.032.560.680
Phospho-p53 (S46)8.84 ± 4.149.08 ± 2.810.240.948
Phospho-p53 (S392)4.06 ± 2.695.01 ± 6.630.950.844
Phospho-Rad17 (S635)12.24 ± 3.8313.16 ± 9.860.920.900
SMAC/Diablo63.31 ± 14.2563.90 ± 12.040.590.956
Survivin23.28 ± 1.4821.28 ± 3.96−2.000.443
TNF RI/TNFRSF1A27.19 ± 3.2425.24 ± 4.74−1.950.599
XIAP53.37 ± 7.7351.67 ± 3.93−1.700.769

All values are in percent of the calibrator (positive control). The change is given in percent points of the calibrator. The data were acquired in three independent experiments.